Schedule & Agenda
BIO brings together leading innovators across the biotech industry for four days of top tier programming in Boston this June.
View more than 100 sessions with over 300 speakers across 17 focus areas at #BIO2023. Check this page regularly for updates and new sessions and speakers.
BIO International Convention
Date
Time
Search Sessions
BIO International Convention
Results
Monday, June 5
12:30 PM - 12:45 PM
Praetego is biopharma company developing first-in-class Advanced Glycation End-product (AGE)…
Session Room 104C
QBiotics is a public unlisted Australian life sciences company that discovers and develops new…
Session Room 103
STALICLA is a clinical stage, precision molecular neuroscience biotech company with a mature…
Session Room 104A
12:45 PM - 1:00 PM
Inimmune is a fast-moving innovative biotechnology company focused on the discovery and development…
Session Room 103
ModeX Therapeutics, an OPKO Health subsidiary, is a clinical-stage biopharmaceutical company…
Session Room 104B
Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to…
Session Room 104A
Starpax has developed a never before seen technology that guides in 3D Magnetodrones™ in tumors…
Session Room 104C
1:00 PM - 1:15 PM
Glycostem is focused on the development of first and second generation stem cell-derived Natural…
Session Room 103
OculoTherapy is an early-stage start-up with a novel IOP-lowering eye drop for use in patients with…
Session Room 104B
Ordaōs is a human-enabled, machine-driven drug design company that creates novel and customized…
Session Room 104A
1:15 PM - 1:30 PM
Biocytogen is a global biotechnology company that drives the research and development of novel…
Session Room 103
We are a clinical-stage biotechnology company dedicated to the discovery and development of…
Session Room 104C
NexThera Co., Ltd. is a biotech venture company that utilizes its recombinant protein-based…
Session Room 104B
VerImmune Inc (www.verimmune.com) is a biotechnology company developing a novel Virus-inspired…
Session Room 104A
1:30 PM - 1:45 PM
Atreca is a clinical-stage biotech company inverting the traditional approach to cancer drug…
Session Room 103
CXL Ophthalmics (CXLO) is developing innovative treatments for corneal diseases with the goal of…
Session Room 104B
We are a global biotechnology company focused on further improving and leveraging the patented and…
Session Room 104A
1:45 PM - 2:00 PM
AVEO Oncology, an LG Chem Company, is a commercial stage, oncology-focused biopharmaceutical…
Session Room 103
DeepCure is building a different kind of AI biotech company. DeepCure’s AI is harnessing the power…
Session Room 104A
Nicox is an international ophthalmology company developing innovative therapeutics to help maintain…
Session Room 104B
2:00 PM - 2:15 PM
BYOMass is a preclinical pharmaceutical company developing novel biologic and small molecule drugs…
Session Room 104C
Centivax’s mission is to accelerate the world’s transition to a post-pathogen humanity.
…
Session Room 104B
Glycan Therapeutics is a pioneer in design and synthesis of structurally homogeneous…
Session Room 104A
PharmAbcine Inc. is a clinical stage public company developing next generation antibody…
Session Room 103
2:15 PM - 2:30 PM
Aeolian Biotech is reaching for an improved pneumococcal vaccine. Our management team includes…
Session Room 104B
We are a clinical-stage biopharmaceutical company focused on developing novel synthetic lethality…
Session Room 104C
Privo Technologies, Inc. (Privo) is a phase 3 clinical-stage biopharmaceutical company committed to…
Session Room 103
Sibylla Biotech is an early-stage drug discovery company whose primary goal is the identification…
Session Room 104A
2:30 PM - 2:45 PM
Blue Lake is a clinical stage company developing novel intranasal vaccines based on parainfluenza…
Session Room 104B
One carbon therapeutics is developing innovative therapeutics for oncology indications with high…
Session Room 103
Prazer Therapeutics is a Korean biotech company pioneering innovative small molecule therapeutics…
Session Room 104A
Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform…
Session Room 104C
2:45 PM - 3:00 PM
CHA Vaccine Institute (CVI) is a clinical stage biopharmaceutical company developing proprietary…
Session Room 104C
Oxymo Technologies, a French-Canadian biotech, is developing Oximo, a topical drug product for the…
Session Room 104B
Predictive Oncology is a knowledge-driven company disrupting the oncology drug discovery paradigm…
Session Room 103
Founded in 2021, Serna Bio is building the first map of the druggable transcriptome, opening up the…
Session Room 104A
3:00 PM - 3:15 PM
FunPep is a public, late clinical-stage therapeutics company that has developed a functional…
Session Room 104A
Neuro-Innovators, LLC (NIV) is a clinical stage drug company. Its purpose, accelerate brain…
Session Room 103
Rejuvenate Biomed is an independent Belgian biomedical company established in October 2017 by Ann…
Session Room 104C
Vaxxas is developing and commercializing a high-density microarray patch (HD-MAP) as an alternative…
Session Room 104B
3:15 PM - 3:30 PM
We, Aprogen, Inc., are a listed company on the Korea Exchange (007460:KS) with over 20 years of…
Session Room 104C
CytoTronics is commercializing technology emerging from the Harvard University labs to bring unique…
Session Room 104A
NanoViricides, Inc. is developing highly effective & safe antivirals acting by a novel mechanism of…
Session Room 104B
Reconnect Labs is a Swiss, clinical stage pharmaceutical company developing Regenerative…
Session Room 103
3:30 PM - 3:45 PM
Caszyme is a biotech company, based in Vilnius, Lithuania. The company specializes in development…
Session Room 104A
MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain…
Session Room 103
SymBio Pharmaceuticals Limited is a fully integrated, commercial-stage specialty pharmaceutical…
Session Room 104C
3:45 PM - 4:00 PM
We are advancing mRNA Lightning, a novel platform for the discovery of small molecule mRNA drugs…
Session Room 104A
Privately held and financed start up company focused on discovery and development of small…
Session Room 103
Unravel Biosciences is the first rapid prototyping therapeutics company leveraging AI models of…
Session Room 104C
4:00 PM - 4:15 PM
Actinogen is an ASX-listed, biotech company conducting Ph 2 trials of an oral, brain-penetrant…
Session Room 103
The Asahi Kasei Group operates in the three business sectors of Material, Homes, and Health Care…
Session Room 104C
4:15 PM - 4:30 PM
Clinical Stage Neuro Biotechnology company bringing science to Psilocybin to help people raise…
Session Room 103
Shaperon is a clinical stage biotech company developing novel inflammasome inhibitors(small…
Session Room 104C
4:30 PM - 4:45 PM
NEUROBIOGEN prioritizes its research and development efforts to develop innovative new medicine to…
Session Room 103
Rise Therapeutics is a clinical-stage developer of targeted oral immunotherapy drugs that leverages…
Session Room 104C
4:45 PM - 5:00 PM
MirimGENE's target of focus includes WARS among human aminoacyl-tRNA synthetase (ARSs). WARS, …
Session Room 104C
Built on the groundbreaking immuno-neurology research of our scientific founder, Dr. Edgar Engleman…
Session Room 103
5:00 PM - 5:15 PM
AltruBio is a privately held, clinical stage biotechnology company headquartered in San Francisco,…
Session Room 104C
NurrOn Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company dedicated to developing…
Session Room 103
5:15 PM - 5:30 PM
AMPEL BioSolutions is a precision medicine company commercializing a development pipeline of CLIA…
Session Room 104C
At Ferrer we want to promote a new way of doing business and a responsible way of being in the…
Session Room 103
Forge Biologics is a hybrid gene therapy contract manufacturing and clinical-stage therapeutics…
Session Room 104B
Tuesday, June 6
10:45 AM - 11:00 AM
Plakous is a biotherapeutic company developing a patented platform that, in preclinical studies,…
Session Room 104C
11:00 AM - 1:00 PM
We, ARCE Therapeutics, Inc., specialize in developing first and best-in-class gene-modified…
North Lobby
Ardan Pharma is an academic spin off company, investigating one guilty molecule of checkpoint…
North Lobby
Asgard Therapeutics is a Swedish private biotech company advancing cancer immunotherapies by…
North Lobby
Gilboa is a preclinical-stage biopharmaceutical company, co-located in Boston and Israel, that is…
North Lobby
Moleculex has created the world's first "intraoral" wound dressing to treat severe oral ulcers…
North Lobby
At Promakhos Therapeutics, we create therapies for autoinflammatory diseases based on a new and…
North Lobby
Saros Therapeutics is developing an innate immune activation technology for oncology. While…
North Lobby
11:00 AM - 11:15 AM
Eupraxia is a clinical-stage biotechnology company focused on the development of locally delivered,…
Session Room 104C
11:15 AM - 11:30 AM
Adiso Therapeutics, Inc. is an innovative, private, clinical-stage biopharmaceutical company…
Session Room 104C
11:15 AM - 11:45 AM
A leader in the biomedical revolution, Stanford Medicine has a long tradition of leadership in…
Session Room 104B
11:30 AM - 11:45 AM
Merck has a strong history of success in translating cutting-edge research into life-saving medical…
Session Room 104B
SynAct Pharma AB is a clinical stage biotechnology company focused on the resolution of…
Session Room 104C
11:45 AM - 12:00 PM
Paradigm Biopharmaceuticals Ltd. (ASX:PAR) is a late-stage drug development company driven by a…
Session Room 104C
12:00 PM - 12:15 PM
Genentech pioneered the biotech industry and revolutionized how we treat some of the world’s most…
Session Room 104B
12:15 PM - 12:30 PM
AIVITA Biomedical is a biotechnology company developing personalized vaccines for the prevention of…
Session Room 103
1:45 PM - 2:00 PM
GSK is a global biopharma company with a purpose to unite science, technology, and talent to get…
Session Room 104B
Healx is an AI-powered techbio company redesigning drug discovery to develop treatments for rare…
Session Room 104C
Virtual Clinical stage (Phase 3 ready) Ophthalmology focused company with a lead molecule for…
Session Room 103
2:00 PM - 4:00 PM
48Hour Discovery (48HD) is a leading peptide-based platform accelerating discovery of novel…
North Lobby
Anticipate Bioscience is built on 5 years of world class medicinal chemistry by a veteran oncology…
North Lobby
FELIQS, a Japanese startup company funded with a seed round of $2.5 million, develops a portfolio…
North Lobby
MC Sciences is developing the Next Generation Therapeutics targeting mast cells. Based on the…
North Lobby
The Native Cell Membrane Nanoparticle (NCMN) system is GPCR targeted, detergent-free protein…
North Lobby
T-E Meds, Inc. is a subsidiary company of T-E Pharma Holding which focuses on antibody-drug…
North Lobby
Zehna Therapeutics is developing non-bacteriocidal small molecule inhibitors of a specific gut…
North Lobby
2:00 PM - 2:15 PM
MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company pioneering Precision Endocrine…
Session Room 104C
Novasenta is focused on the discovery of novel therapeutic targets to develop innovative and…
Session Room 103
SANOFI is an innovative global Healthcare company focused on human health.
We are an innovative…
Session Room 104B
2:15 PM - 2:30 PM
HTG is a platform-based drug discovery company using proprietary transcriptome-wide profiling and…
Session Room 103
Novartis provides healthcare solutions that improve and extend people’s lives. We use science-based…
Session Room 104B
ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave…
Session Room 104C
2:30 PM - 2:45 PM
PRG S&Tech is a Korean company specializing in R&D for rare genetic diseases founded in 2017, and…
Session Room 104C
Servier is an independent pharmaceutical company committed to therapeutic progress to serve patient…
Session Room 104B
Theranostec develops precision nanomedicines that significantly improve both the delivery and…
Session Room 103
2:45 PM - 3:00 PM
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and…
Session Room 104C
NuvOx is a Phase IIb platform biotech company. Focusing on reversing hypoxia (lack of oxygen), the…
Session Room 103
Vaxess Technologies is developing the MIMIX™ sustained release patch technology, the easiest and…
Session Room 104A
3:00 PM - 3:15 PM
Chugai Pharmaceutical is one of Japan’s leading research-based pharmaceutical companies with…
Session Room 104B
Osmol is a spin-out of Yale University developing a novel treatment, OSM-0205, to prevent…
Session Room 103
3:15 PM - 3:30 PM
Bridge Biotherapeutics Inc. is a publicly traded clinical-stage biotech company based in the…
Session Room 104B
As NCI SBIR Investor Initiative Awardee, we are leveraging a cutting-edge approach using…
Session Room 103
3:30 PM - 3:45 PM
SIRPant Immunotherapeutics Inc. is focused on the development of novel autologous macrophage cell…
Session Room 103
Zambon Biotech is part of the Zambon group of companies, it is focused in growing the portfolio and…
Session Room 104B
3:45 PM - 4:00 PM
Baseimmune is a discovery stage biotech company developing future-proof antigens. Based on…
Session Room 104C
Fosun Pharma is a gloabl pharmaceutical company
that is patient-centered and clinical needs…
Session Room 104B
Pharos iBio is a clinical stage biotech company that develops novel drug for rare and refractory…
Session Room 103
4:00 PM - 4:15 PM
Hello, we are a startup company established in National Cancer Center (NCC), Korea developing anti…
Session Room 103
SPARK biopharma, Inc. is a clinical-stage drug discovery and development company pursuing…
Session Room 104B
4:15 PM - 4:30 PM
Our commercial flagship products Rexulti, Abilify Maintena, and Jynarque have established Otsuka as…
Session Room 104B
Panavance Therapeutics Inc. is a privately held, clinical-stage pharmaceutical company developing a…
Session Room 103
Tonix is a clinical-stage biopharmaceutical company focused on developing therapeutics and vaccines…
Session Room 104A
4:30 PM - 4:45 PM
Enveda’s novel, proprietary drug discovery platform uses machine learning, metabolomics, and…
Session Room 104B
Kernal Bio is a venture-backed biotech company developing mRNA 2.0 immunotherapies. Kernal Bio…
Session Room 103
4:45 PM - 5:00 PM
Clinical stage company focusing on Radiopharmaceutical Imaging and Therapies in Oncology
Session Room 103
Zymeworks is a global biotechnology company developing novel, multifunctional therapeutics to…
Session Room 104B
Wednesday, June 7
10:30 AM - 10:45 AM
Combined Therapeutics Inc. (CTx) is a privately held biotechnology company developing the next…
Session Room 104B
Lynk Pharmaceuticals, a clinical-stage company with global locations, actively seeks new…
Session Room 103
Peptilogics engineers peptide therapeutic candidates to radically improve the treatment landscape…
Session Room 104A
10:45 AM - 11:00 AM
IAMA Therapeutics is a Series A- late preclinical-stage pharmaceutical company focused on…
Session Room 104B
A clinical stage, specialty pharmaceutical company with a disruptive anti-infective platform…
Session Room 104A
11:00 AM - 11:15 AM
Aruna’s AB126, a therapeutic exosome, is an innovative neural anti-inflammatory and neuromodulator…
Session Room 104B
11:00 AM - 1:00 PM
AyuVis designs and develops novel, small molecule immunotherapies to prevent and treat inflammatory…
North Lobby
Azora Therapeutics is a clinical-stage biopharmaceutical company developing novel small molecule…
North Lobby
ImunoTera is a spin off from University of Sao Paulo (USP), considered the best university in
Latin…
North Lobby
Despite advances in surgical glues and hemostatic patches, 30-50% of surgeries still suffer from…
North Lobby
We're developing mitochondrial protective small molecules for epilepsy, Parkinson's and…
North Lobby
Paradox Immunotherapeutics is an orphan drug company that develops immunotherapies for protein…
North Lobby
Reglagene is a therapeutics company transforming tubulin targeting therapy for brain diseases…
North Lobby
11:15 AM - 11:30 AM
Alchemab has developed a highly differentiated platform which enables the identification of novel…
Session Room 104B
Mitotherapeutix is a preclinical stage pharmaceutical company that is focused on the development of…
Session Room 104C
11:30 AM - 11:45 AM
CK Regeon (CKR) provides innovative approaches to develop novel small molecules which can treat…
Session Room 104C
IRR is a science-based drug development company focused on pharmaceutical products for the…
Session Room 104B
11:45 AM - 12:00 PM
MEPSGEN, a biotech company founded by Dr. YongTae Kim and Dr. Robert Langer in 2019, develops and…
Session Room 104B
12:00 PM - 12:15 PM
Concarlo Therapeutics is a preclinical-stage oncology company developing transformative…
Session Room 104A
Energesis Pharmaceuticals is developing a new class of highly differentiated drugs that -- unlike…
Session Room 104C
Immuneering is a clinical-stage oncology company developing medicines for broad populations of…
Session Room 103
Muscle toning drug for multiple applications including sleep apnoea, cosmetics such as ectropion…
Session Room 104B
12:15 PM - 12:30 PM
Breakpoint Therapeutics GmbH is a pre-clinical stage company dedicated to the discovery and…
Session Room 104A
OncoHost is a commercial-stage precision oncology company headquartered in Binyamina, Israel, and…
Session Room 104B
Presentation Description: Phanes Biotech is a biotech company developing novel therapies for the…
Session Room 104C
1:45 PM - 2:00 PM
Baiya Phytopharm is an Asia based biotech company established by a global leader in plant-based…
Session Room 103
Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop…
Session Room 104B
Enterome is a clinical stage company developing off-the-shelf, transformational cancer treatments…
Session Room 104A
Sinopia Biosciences is a biotechnology company leveraging a multi-omics powered AI/ML drug…
Session Room 104C
2:00 PM - 4:00 PM
ARIZ Precision Medicine (pronounced “Arise”) is developing first in class cancer therapeutics based…
North Lobby
CorriXR Therapeutics is an oncology-focused biotherapeutics development company enabled by a novel…
North Lobby
Cyta Therapeutics is a pre-clinical company developing therapies for cardiometabolic diseases…
North Lobby
FAKnostics is a dynamic pharmaceutical and diagnostics company, developing next generation drugs…
North Lobby
Grannus Therapeutics is a pre-clinical platform company focused on developing and commercializing…
North Lobby
Guardian Bio is a cancer therapeutics platform creating the next generation of cell therapies to…
North Lobby
March Biosciences, Inc is a clinical-stage cell therapy company with a mission to transform patient…
North Lobby
MelliCell is a pre-clinical biotechnology company with innovative technology to develop…
North Lobby
OmniCyte is a preclinical Immunology company. Our therapeutics are developed on our proprietary,…
North Lobby
2:00 PM - 2:15 PM
Galapagos is a fully integrated biotechnology company focused on discovering, developing and…
Session Room 104A
ImmunoChem Therapeutics, a Phase 2 clinical stage, Northwestern University spin-out, is developing…
Session Room 104C
Synaffix BV is a biotech company that has established a proprietary, clinical-stage technology…
Session Room 103
2:15 PM - 2:30 PM
Atomic AI is an emerging biotechnology company exploiting the fusion of artificial intelligence and…
Session Room 103
Boehringer Ingelheim is working on breakthrough therapies that transform lives, today and for…
Session Room 104B
Courage Therapeutics is a pre-clinical biotech company focused on feeding behavior. The company has…
Session Room 104C
MAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on development of…
Session Room 104A
2:30 PM - 2:45 PM
Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company,…
Session Room 104B
Sensei Biotherapeutics (NASDAQ: SNSE) is an immuno-oncology company focused on the discovery and…
Session Room 104A
Synthego was founded to revolutionize genome engineering technology, helping translate genomics…
Session Room 103
Vincere Biosciences is developing AI-derived mitochondrial targeted therapeutics with a mission to…
Session Room 104C
2:45 PM - 3:00 PM
Algen is a platform therapeutics and drug discovery company using the world’s leading CRISPR and AI…
Session Room 103
IMUNON is a fully integrated, clinical-stage biotechnology company focused on advancing a portfolio…
Session Room 104A
Navigo Proteins is a fast-growing German biotech developing next-generation targeted therapeutics,…
Session Room 104B
Praxis Bioresearch is an NIH Innovation Zone Company developing a novel treatment for behavioral…
Session Room 104C
3:00 PM - 3:15 PM
Affivant is a Basel, Switzerland based biotech company developing innate immune cell engagers for…
Session Room 104B
Lokon Pharma is a privately owned, Swedish biotech company developing immunostimulatory gene…
Session Room 104A
St. Jude Children's Research Hospital is a non-profit pediatric research institution. The mission…
Session Room 104C
3:15 PM - 3:30 PM
Macro Biologics’ innovative technology platform creates synthetic biological polymers (macro…
Session Room 104C
Rakuten Medical, Inc. is a global biotechnology company developing and commercializing precision,…
Session Room 104A
Solaxa is a clinical-stage, bio-pharmaceutical, start-up company developing and commercializing…
Session Room 104B
3:30 PM - 3:45 PM
We are a clinical-stage biopharmaceutical company focused on the development of GP2, an…
Session Room 104A
MicuRx was founded by Dr. Zhengyu Yuan and Dr. Mikhail F. Gordeev, and is led by an experienced,…
Session Room 104B
We are an innovative biopharmaceutical company developing and commercializing a pipeline of drug…
Session Room 104C
3:45 PM - 4:00 PM
Kintara Therapeutics is a clinical stage drug development company with a focus on the development…
Session Room 104A
SAB Biotherapeutics is a clinical-stage biopharmaceutical company focused on the development of…
Session Room 104B
3:45 PM - 4:30 PM
LinusBio is a patient-centric, precision exposome medicine company, originating from the world’s…
Session Room 104C
4:00 PM - 4:15 PM
Affini-T is unlocking the power of T cells and targeting core oncogenic drivers to develop…
Session Room 104B
Bolden Therapeutics is a preclinical-stage biotechnology company developing first-in-class…
Session Room 104C
With more than 65 years of experience in delivering life-changing science, Lantheus is committed to…
Session Room 104A
4:15 PM - 4:30 PM
Arpeggio makes medicine to alter gene expression and fight drug resistance in cancer. We do this by…
Session Room 104B
Genesis Therapeutics has created the industry's most advanced molecular AI platform by combining…
Session Room 104C
Like real-time traffic data revolutionized how we drive, Pepper Bio, the world’s first transomics…
Session Room 104A
4:30 PM - 4:45 PM
At Avstera, our primary focus is to address the significant unmet need of cancer patients failing…
Session Room 104B
CancerFree Biotech is a start-up company dedicated to personalized treatment of cancer.
We…
Session Room 104A
FELIQS, a Japanese startup company funded with a seed round of $2.5 million, develops a portfolio…
Session Room 104C
4:45 PM - 5:00 PM
Accession Therapeutics is developing a new generation of immunotherapies for solid tumors.
…
Session Room 104B
AI Proteins is re-imagining the possibilities of protein therapeutics by rationally designing…
Session Room 104C
NeoImmuneTech (NIT) is a T-cell Centric IO Company and the Global Leader in Interleukin (IL-7). At…
Session Room 104A
Thursday, June 8
10:30 AM - 10:45 AM
Covant’s mission is to treat diseases with transformative therapeutics using covalency to modulate…
Session Room 104A
Modulus Discovery, Inc., is a pre-clinical stage biotechnology company with a cutting-edge…
Session Room 103
11:00 AM - 1:00 PM
AnHorn Medicines is a drug discovery platform company with a strong pipeline, offering therapies…
North Lobby
Immuto Scientific is on a mission to drug the 'undruggable'. We enable the discovery of first-in…
North Lobby
pacDNA is transforming the field of gene regulation therapeutics with our proprietary Brushield™…
North Lobby
Phase 3 ready rare disease company focused on MCT8 deficiency (a.k.a. Allan-Herndon Dudley Syndrome…
North Lobby
11:00 AM - 11:15 AM
ITabMed Ltd. is a clinical-stage biotech company developing immunotherapy antibodies (ITAbTM) to…
Session Room 103
11:15 AM - 11:30 AM
Cyrus Biotechnology is a pre-clinical-stage biotech company combining computational protein
…
Session Room 104A
KaliVir Immunotherapeutics is a private biotechnology company dedicated to developing systemically…
Session Room 103
11:30 AM - 11:45 AM
PeptiDream Inc. (Tokyo Stock Exchange: 4587) is leading the translation of macrocyclic peptides…
Session Room 104A
Phanes is a clinical stage biotech focused on innovative drug discovery and development in oncology…
Session Room 103
11:45 AM - 12:00 PM
Clinical-stage biopharmaceutical company developing therapeutics for the treatment of central…
Session Room 104A
12:00 PM - 12:15 PM
BIORCHESTRA is a biotherapeutics company focused on degenerative and rare Central Nervous System …
Session Room 104A
FivepHusion is an advanced clinical stage biotech company developing Deflexifol™, a novel enhanced…
Session Room 103
12:15 PM - 1:00 PM
Protibea is a clinical stage company whose product has been dosed in 200+ patients for up to one…
Session Room 104A
12:30 PM - 12:45 PM
Henlius is a global biopharmaceutical company with the vision to offer high-quality, affordable,…
Session Room 103
Precision NanoSystems, now part of the Danaher Life Sciences platform, is a global leader in…
Session Room 104A
12:45 PM - 1:00 PM
Co-founded by Professor Junying Yuan and Professor Jidong Zhu, two leading scientists in cell death…
Session Room 103
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
